// App-Quantinova.ai

1368 : Prognostic Significance Of CRLF2 Over-Expression In Pediatric Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Mio Yano

Principal Investigators

  • Daisuke Asai

  • Koji Kato

  • Keizo Horibe

  • Keiko Yagi

  • Junichi Hara

  • Kenji Matsumoto

  • Nobutaka Kiyokawa

  • Megumi Oda

  • Atsushi Sato

  • Akiko Moriya Saito

  • So-ichi Suenobu

  • Daiichiro Hasegawa

  • Takao Deguchi

  • Yoshiko Hashii

  • Hirohide Kawasaki

  • Hiroki Hori

  • Yoshiyuki Kosaka

Medical Centers

  • The Japan Association of Childhood Leukemia Study, Osaka, Japan

  • The Japan Association of Childhood Leukemia Study, Osaka, Japan

  • The Japan Association of Childhood Leukemia Study, Osaka, Japan

  • Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Tokyo, Japan

  • Kobe Childre-s Hospital, Department of Hematology and Oncology, Kobe, Japan

  • Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Tokyo, Japan

  • Department of Obstetrics and Gynecology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan

  • Clinical Rsch Cntr, National Hosp Organization, Nagoya Med Cntr, Nagoya, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved